市場調查報告書
商品編碼
1394972
裸金屬支架市場規模- 按產品(自擴張式、球囊擴張式)、材料類型(不銹鋼、鈷鉻合金、鎳鈦合金)、應用(冠狀動脈、外周動脈)、最終用途(醫院、ASC)和預測,2023 年- 2032Bare Metal Stents Market Size - By Product (Self-expandable, Balloon Expandable), Material Type (Stainless Steel, Cobalt-Chromium Alloy, Nitinol), Application (Coronary, Peripheral), End-use (Hospitals, ASCs) & Forecast, 2023 - 2032 |
在由頂尖研究人員主導的旨在理解和評估這些設備的廣泛研究工作的推動下,全球裸金屬支架市場在 2023 年至 2032 年間CAGR將達到 2.8%。隨著研究加深對裸金屬支架功效和限制的了解,該市場出現了激增。
例如,2023年6月,WL Gore & Associates (Gore)啟動了Gore VBX FORWARD臨床研究,以評估VBX覆膜支架與裸金屬支架在治療複雜性髂閉塞性疾病的有效性。對性能、耐用性和相容性的不懈追求推動了這一需求。隨著領先的研究人員深入研究最佳化設計和材料成分,他們的發現推動了裸金屬支架的市場需求,塑造了裸金屬支架在現代醫療實踐中的演變和應用。
整個裸金屬支架行業根據產品、應用和地區進行分類。
自膨脹支架領域將在 2023 年至 2032 年期間經歷重大發展。這些先進的支架具有多功能性和適應性,可適應複雜的解剖結構。憑藉其自擴張能力,這些支架可提供精確的部署和安全的血管支撐。隨著醫生尋求高效、微創的解決方案,對自膨脹裸金屬支架的需求激增。它們適應不同血管尺寸和複雜性的能力標誌著一個關鍵的轉變,推動裸金屬支架市場的成長軌跡,以追求改善患者的治療結果和提高手術效果。
2023年至2032年,週邊動脈段的複合CAGR將顯著。隨著週邊動脈疾病的增加,裸金屬支架將成為恢復血流和提供結構支撐的重要工具。隨著醫療介入優先考慮微創手術,對這些支架的需求不斷增加。它們加強狹窄動脈並保持血管通暢的能力滿足了周邊動脈介入治療的關鍵需求,反映了裸金屬支架市場因可靠和高效的治療選擇而擴張。
亞太地區裸金屬支架市場將在2023年至2032年呈現出值得稱讚的CAGR。隨著人口的迅速成長和心血管疾病患病率的增加,迫切需要有效的治療解決方案。
裸金屬支架在這種情況下發揮關鍵作用,為動脈疾病管理提供了經濟高效且可靠的選擇。隨著該地區注重先進的醫療干預措施,對這些支架的需求激增,反映出它們在解決整個亞太地區心血管健康挑戰方面的關鍵作用。例如,2023 年 4 月,印度在批發價格指數 (WPI) 修訂後提高了冠狀動脈支架的價格上限,包括裸金屬支架和藥物洗脫支架。根據國家藥品定價局 (NPPA) 的指令,裸金屬支架的最高價格調整為 10,509 盧比。
Global Bare Metal Stents Market will witness 2.8% CAGR between 2023 and 2032, driven by extensive research endeavors aimed at comprehending and appraising these devices, spearheaded by top researchers. As studies deepen the understanding of bare metal stents' efficacy and limitations, this market witnesses a surge.
For instance, in June 2023, W. L. Gore & Associates (Gore) initiated the Gore VBX FORWARD Clinical Study to evaluate the effectiveness of the VBX Stent Graft compared to bare metal stenting in treating complex iliac occlusive disease. The relentless pursuit of insights into their performance, durability, and compatibility fuels this demand. As leading researchers delve deeper into optimizing design and material compositions, their findings propel the bare metal stents market demand, shaping the evolution and applications of bare metal stents in modern medical practices.
The overall Bare Metal Stents Industry is classified based on product, application, and region.
Self-expandable stent segment will undergo significant development from 2023 to 2032. These advanced stents offer versatility and adaptability, catering to intricate anatomical structures. With their self-expanding capability, these stents provide precise deployment and secure vessel support. As medical practitioners seek efficient and minimally invasive solutions, the demand for self-expanding bare metal stents skyrockets. Their ability to conform to diverse vessel sizes and complexities marks a pivotal shift, propelling the bare metal stents market growth trajectory in the pursuit of improved patient outcomes and enhanced procedural efficacy.
Peripheral artery segment will register a noteworthy CAGR from 2023 to 2032. With peripheral artery diseases on the rise, bare metal stents serve as vital tools in restoring blood flow and providing structural support. As medical interventions prioritize minimally invasive procedures, the demand for these stents escalates. Their ability to reinforce narrowed arteries and maintain vessel patency addresses critical needs in peripheral artery interventions, reflecting the bare metal stents market expansion from reliable and efficient treatment options.
Asia Pacific bare metal stents market will showcase a commendable CAGR from 2023 to 2032. With a burgeoning population and increased prevalence of cardiovascular diseases, there's a pressing need for effective treatment solutions.
Bare metal stents play a pivotal role in this scenario, offering cost-effective and reliable options for artery disease management. As the region focuses on advanced medical interventions, the demand for these stents soars, reflecting their crucial role in addressing cardiovascular health challenges across Asia Pacific. For instance, in April 2023, in India, the price caps on coronary stents, covering both bare metal and drug-eluting variants, were raised following the Wholesale Price Index (WPI) revision. As per the directive from the National Pharmaceutical Pricing Authority (NPPA), the maximum price for bare metal stents was adjusted to Rs 10,509.